Corcept Therapeutics (CORT) Exchange Rate Effect (2024 - 2026)
Corcept Therapeutics (CORT) posted Exchange Rate Effect of $37000.0 for Q2 2026, up 112.89% sequentially from -$287000.0 in Q1 2026, and down 97.42% YoY from $1.4 million in Q2 2025.
Corcept Therapeutics (CORT) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Corcept Therapeutics has reported Exchange Rate Effect for 3 years, with the latest figure at $37000.0 in Q2 2026.
- Quarterly Exchange Rate Effect fell 97.42% year-over-year to $37000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$602000.0 (down 138.3% YoY) and the FY2025 annual result came in at $1.4 million, up 732.46% from the prior year.
- Exchange Rate Effect improved to $37000.0 in Q2 2026 per CORT's latest filing, from -$287000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $1.4 million in Q2 2025 and troughed at -$758000.0 in Q4 2024.
- A 3-year average of $121250.0 and a median of $2500.0 in 2025 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect soared 95.78% in 2025, then plunged 180.17% in 2026.
- Over 3 years, Exchange Rate Effect stood at -$758000.0 in 2024, then jumped by 95.78% to -$32000.0 in 2025, then jumped by 215.62% to $37000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $37000.0, -$287000.0, and -$32000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 37,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37,000.00 |
| Jun 30, 2026 | 37,000.00 |
| Mar 31, 2026 | -287,000.00 |
| Mar 31, 2026 | -287,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Sep 30, 2025 | -320,000.00 |
| Sep 30, 2025 | -320,000.00 |
| Jun 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 358,000.00 |
| Mar 31, 2025 | 358,000.00 |
| Dec 31, 2024 | -758,000.00 |
| Dec 31, 2024 | -758,000.00 |
| Sep 30, 2024 | 536,000.00 |
| Sep 30, 2024 | 536,000.00 |